Viewing Study NCT05609903


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-01-05 @ 12:14 AM
Study NCT ID: NCT05609903
Status: COMPLETED
Last Update Posted: 2022-11-08
First Post: 2022-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module